Premium
Most parents would support school HPV vaccine requirements if offered opt‐out provisions
Author(s) -
Printz Carrie
Publication year - 2016
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30442
Subject(s) - opt out , medicine , statement (logic) , family medicine , cancer prevention , human papillomavirus , medical education , law , political science , cancer , business , advertising
Cancer December 1, 2016 CANCER DECEMBER 1, 2016 3 Content in this section does not reflect any official policy or medical opinion of the American Cancer Society or of the publisher unless otherwise noted. © American Cancer Society, 2016. at the University of North Carolina at Chapel Hill.1 He and his colleagues conducted a web-based survey of 1501 parents between November 2014 and January 2015. Respondents had to have at least 1 child aged 11 to 17 years living primarily in their household. The survey asked parents about this statement: “Some states are trying to pass laws that would require all 11and 12-year olds to get the HPV vaccine before they are allowed to start 6th grade.” Overall, 21% of participants agreed that such laws were a good idea, 54% disagreed, and 25% said they neither agreed nor disagreed. Dr. Calo says that the latter group may benefit from public education regarding HPV vaccination and, as they learn about the benefits of vaccination, be more likely to support schoolentry requirements. The respondents who disagreed that the laws were a good idea were presented with a follow-up statement: “Is it okay to have these laws only if parents can opt out when they want to?” When this provision was added, approximately 57% of respondents agreed that school-entry requirements were a good idea whereas 21% disagreed. Among other findings: • Nearly one-third of respondents believed that the vaccine was being promoted to make money for drug companies. • Approximately 40% believed that the vaccine was effective in preventing cervical cancer. Dr. Calo notes that changing some of those perceptions would help to improve HPV vaccination rates along with legislating school-entry requirements. He adds that any optout provisions also have the potential to weaken the overall effectiveness of HPV vaccination if large numbers of families opt out. As a result, such an option also should include an educational component to encourage patients to carefully consider their decision, he says. States should consider school-entry requirements for HPV vaccination after implementing other approaches, such as centralizing vaccination reminders in state health departments, focusing on HPV vaccination during quality improvement visits to providers, and training physicians to use announcements to introduce vaccination, Dr. Calo notes.